Shaobo Pei
Overview
Explore the profile of Shaobo Pei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patel S, Walsh J, Pinnell D, Pei S, Chen W, Rojas J, et al.
Medicine (Baltimore)
. 2024 Sep;
103(37):e39476.
PMID: 39287304
The Veterans Health Administration (VHA) listed the infliximab (IFX) biosimilar, IFX-dyyb (Inflectra), on the Veterans Affairs National Formulary (VANF) in May 2017. In September 2018, biosimilar IFX-abda (Renflexis) became the...
2.
Walsh J, Pei S, Alexander S, Braaten T, Walker J, Clewell J, et al.
Semin Arthritis Rheum
. 2024 May;
66:152436.
PMID: 38714073
Objective: To identify factors associated with non-treatment with biologic and non-biologic disease modifying anti-rheumatic drugs (DMARDs) during the 12 months after initial inflammatory arthritis (IA) diagnosis. Methods: We identified Veterans...
3.
Walsh J, Pei S, Penmetsa G, Overbury R, Clegg D, Sauer B
J Rheumatol
. 2020 Dec;
48(5):685-692.
PMID: 33259327
Objective: Observational research of axial spondyloarthritis (axSpA) is limited by a lack of methods for identifying diverse axSpA phenotypes in large datasets. Algorithms were previously designed to identify a broad...
4.
Walsh J, Pei S, Penmetsa G, Sauer B, Patil V, Walker J, et al.
J Manag Care Spec Pharm
. 2019 Oct;
25(11):1218-1228.
PMID: 31663467
Background: Delays in treatment for inflammatory arthritis (IA) are associated with unfavorable outcomes, including impaired quality of life, irreversible joint damage, and disability. Objective: To characterize treatment initiation patterns in...
5.
Walsh J, Pei S, Penmetsa G, Hansen J, Cannon G, Clegg D, et al.
J Rheumatol
. 2019 Mar;
47(1):42-49.
PMID: 30877217
Objective: Observational axial spondyloarthritis (axSpA) research in large datasets has been limited by a lack of adequate methods for identifying patients with axSpA, because there are no billing codes in...
6.
Walsh J, Pei S, Penmetsa G, Leng J, Cannon G, Clegg D, et al.
BMC Musculoskelet Disord
. 2018 Sep;
19(1):317.
PMID: 30185185
Background: Big data research is important for studying uncommon diseases in real-world settings. Most big data studies in axial spondyloarthritis (axSpA) have been limited to populations identified with billing codes...
7.
Walsh J, Pei S, Burningham Z, Penmetsa G, Cannon G, Clegg D, et al.
J Rheumatol
. 2017 Nov;
45(3):430-436.
PMID: 29142040
Objective: To evaluate the effect of access to and distance from rheumatology care on the use of disease-modifying antirheumatic drugs (DMARD) in US veterans with inflammatory arthritis (IA). Methods: Provider...
8.
Han Y, Buffolo M, Pires K, Pei S, Scherer P, Boudina S
Diabetes
. 2016 Jun;
65(9):2639-51.
PMID: 27284109
Obesity and insulin resistance are associated with oxidative stress (OS). The causal role of adipose OS in the pathogenesis of these conditions is unknown. To address this issue, we generated...
9.
Fullmer T, Pei S, Zhu Y, Sloan C, Manzanares R, Henrie B, et al.
J Mol Cell Cardiol
. 2013 Sep;
64:20-9.
PMID: 23994159
It is believed that the diabetic myocardium is refractory to cardioprotection by ischemic preconditioning (IPC) mainly because of impaired insulin signaling to phosphatidylinositol 3-kinase (PI3K) and protein kinase B (PKB...
10.
Boudina S, Han Y, Pei S, Tidwell T, Henrie B, Tuinei J, et al.
Diabetes
. 2012 Aug;
61(12):3260-9.
PMID: 22912419
These studies investigate the role of uncoupling protein 3 (UCP3) in cardiac energy metabolism, cardiac O(2) consumption (MVO(2)), cardiac efficiency (CE), and mitochondrial uncoupling in high fat (HF)-fed or leptin-deficient...